This condition — the plain-language one-pager.

What is Inflammatory Bowel Disease?Diagnosis

Inflammatory Bowel Disease (IBD) is chronic immune-mediated inflammation of the GI tract. The two main forms are Crohn's disease (can affect any part of the GI tract from mouth to anus, often skip lesions, transmural — predisposes to fistulas/strictures) and ulcerative colitis (limited to the colon, continuous from rectum, mucosal). About 3 million Americans have IBD. The modern era brought biologics + small molecules that target specific immune pathways — and many patients now achieve sustained remission with normal quality of life.

• Symptoms — Diarrhea (often bloody in UC), abdominal pain, weight loss, fatigue, urgency. Extraintestinal: arthritis, uveitis, primary sclerosing cholangitis, pyoderma gangrenosum, erythema nodosum.
• Diagnosis — Colonoscopy with biopsies (gold standard); CT/MR enterography for small bowel; capsule endoscopy; lab markers (CRP, fecal calprotectin); rule out infection (stool studies including C. difficile).
• Treatment toolbox (huge expansion) — 5-ASAs (mesalamine — UC mostly); steroids (induction only, never maintenance); immunomodulators (azathioprine, methotrexate); biologics (anti-TNF: infliximab, adalimumab; anti-integrin: vedolizumab; anti-IL-23: ustekinumab, risankizumab, mirikizumab; anti-IL-12/23); JAK inhibitors (tofacitinib, upadacitinib); S1P modulators (ozanimod). Surgery for refractory disease, dysplasia, perforation, fistula.
• Disease monitoring — Symptoms + biomarkers (calprotectin, CRP) + endoscopy. Treat-to-target: aim for endoscopic remission, not just symptom control. Calprotectin trends predict flares before symptoms.

Treat-to-target — endoscopic remission is the goal, not just symptom controlKnow your plan

For decades IBD treatment chased symptoms. Modern STRIDE-II guidelines say chase the inflammation: aim for endoscopic remission. Patients who achieve mucosal healing have far fewer hospitalizations, surgeries, and cancer risk — and they feel better long-term too.

• Targets — Symptom remission + normal CRP + normal calprotectin (<150 µg/g) + endoscopic remission (Mayo 0-1 in UC; SES-CD ≤2 in Crohn's).
• Monitor calprotectin every 3-6 months — flag rising trends before symptoms return.
• Therapeutic drug monitoring — biologic levels + antibodies guide dose adjustments.
• Surveillance colonoscopy — chromoendoscopy or high-def WL with random biopsies; long-standing colitis = elevated CRC risk; q1-3 years per protocol.
• Vaccine status pre-biologic — flu, COVID, pneumococcal, hepatitis B, shingles (recombinant zoster); avoid live vaccines on most biologics.

Your daily Force FieldLive It

• Take all maintenance therapy on schedule — biologics (subcutaneous or IV per protocol), oral immunomodulators, 5-ASA. Never stop without team consultation.
• Calprotectin every 3-6 months; CRP, CBC, BMP regularly; biologic level + antibody when in doubt.
• Annual colonoscopy or per-protocol surveillance — especially long-standing colitis, PSC, family CRC history.
• No NSAIDs (trigger flares); cautious use of antibiotics; report new GI symptoms early.
• Mediterranean-style or specific carbohydrate diet may help; partial enteral nutrition can induce remission in pediatric Crohn's; iron, B12, vitamin D, calcium repletion.
• Vaccines current before any biologic; avoid live vaccines on most biologics; annual flu + COVID; pneumococcal, RSV, hepatitis B, shingles.
• No tobacco — worse Crohn's; complicated picture for UC; on balance avoid.
• Mental health — depression and anxiety prevalence elevated in IBD; screen and treat; gut-directed CBT and hypnotherapy help.
• Family planning + pregnancy — most biologics safe; preconception counseling; aim for remission entering pregnancy.
• Bone density — DXA at baseline + per protocol on steroids; vitamin D + calcium.

Red flags — call nowAction

• Call your clinic the same day for: new chest discomfort with exertion that goes away with rest (stable abdominal pain worth evaluating); a missed dose of antiplatelet or maintenance therapy; medication side effects (muscle aches, bleeding, GI symptoms).
• Bring up at next visit: any change in exercise tolerance, lipid follow-up timing, BP log review, smoking-cessation support, depression screening, sleep concerns.